Macusine BCAS# 6792-07-0 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 6792-07-0 | SDF | Download SDF |
| PubChem ID | 6441303 | Appearance | Powder |
| Formula | C20H25N2O | M.Wt | 309.4 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC=C1C[N+]2(C3CC1C(C2CC4=C3NC5=CC=CC=C45)CO)C | ||
| Standard InChIKey | KRTATNOTKFNEFT-JQERTRITSA-N | ||
| Standard InChI | InChI=1S/C20H25N2O/c1-3-12-10-22(2)18-9-15-13-6-4-5-7-17(13)21-20(15)19(22)8-14(12)16(18)11-23/h3-7,14,16,18-19,21,23H,8-11H2,1-2H3/q+1/b12-3-/t14-,16+,18?,19+,22-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Macusine B is a dual inhibitor, has almost equal inhibitory activity on both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). |
| Targets | AChR | BChE |
Macusine B Dilution Calculator
Macusine B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.2321 mL | 16.1603 mL | 32.3206 mL | 64.6412 mL | 80.8016 mL |
| 5 mM | 0.6464 mL | 3.2321 mL | 6.4641 mL | 12.9282 mL | 16.1603 mL |
| 10 mM | 0.3232 mL | 1.616 mL | 3.2321 mL | 6.4641 mL | 8.0802 mL |
| 50 mM | 0.0646 mL | 0.3232 mL | 0.6464 mL | 1.2928 mL | 1.616 mL |
| 100 mM | 0.0323 mL | 0.1616 mL | 0.3232 mL | 0.6464 mL | 0.808 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Homobaldrinal
Catalog No.:BCN2681
CAS No.:67910-07-0
- Dehydroevodiamine
Catalog No.:BCN2974
CAS No.:67909-49-3
- Aluminum n-octacosoxide
Catalog No.:BCC8099
CAS No.:67905-27-5
- Ambrox
Catalog No.:BCN6907
CAS No.:6790-58-5
- Scutebarbatine K
Catalog No.:BCN3223
CAS No.:960302-86-7
- Cyclo(Pro-Trp)
Catalog No.:BCN2422
CAS No.:67889-75-2
- Gigantol
Catalog No.:BCN8382
CAS No.:67884-30-4
- n-Butyl-β-D-fructopyranoside
Catalog No.:BCC9097
CAS No.:67884-27-9
- Martynoside
Catalog No.:BCN4236
CAS No.:67884-12-2
- Deapi-platycodin D3
Catalog No.:BCN3240
CAS No.:67884-05-3
- Glycosolone
Catalog No.:BCN6521
CAS No.:67879-81-6
- Caftaric acid
Catalog No.:BCN2096
CAS No.:67879-58-7
- Mesaconine
Catalog No.:BCC8339
CAS No.:6792-09-2
- 1,6-Dihydro-4,7'-epoxy-1-methoxy-3',4'-methylenedioxy-6-oxo-3,8'-lignan
Catalog No.:BCN6584
CAS No.:67920-48-3
- Sodium Danshensu
Catalog No.:BCN5952
CAS No.:67920-52-9
- Aurantio-obtusin
Catalog No.:BCN1222
CAS No.:67979-25-3
- N-(5,8,11,14-Eicosatetraenoyl)taurine
Catalog No.:BCN1755
CAS No.:679834-28-7
- N-(15-Methyl-9-hexadecenoyl)taurine
Catalog No.:BCN1754
CAS No.:679834-30-1
- BMS 193885
Catalog No.:BCC7613
CAS No.:679839-66-8
- Sodium citrate
Catalog No.:BCC7588
CAS No.:68-04-2
- Vitamin B12
Catalog No.:BCC4878
CAS No.:68-19-9
- Norethindrone
Catalog No.:BCC4811
CAS No.:68-22-4
- Vitamin A
Catalog No.:BCN8349
CAS No.:68-26-8
- Sulfadiazine
Catalog No.:BCC3859
CAS No.:68-35-9
New Indole Alkaloids from the Bark of Rauvolfia Reflexa and their Cholinesterase Inhibitory Activity.[Pubmed:26584298]
Cell Physiol Biochem. 2015;37(5):1997-2011.
BACKGROUND/AIMS: Rauvolfia reflexa is a member of the Apocynaceae family. Plants from the Apocynaceae family have been traditionally used in the treatment of age-related brain disorders Methods and Results: Two new indole alkaloids, rauvolfine C (1) and 3-methyl-10,11-dimethoxy-6-methoxycarbonyl-beta-carboline (2), along with five known, Macusine B (3), vinorine (4), undulifoline (5), isoresrpiline (6) and rescinnamine (7) were isolated from the bark of Rauvolfia reflexa. Cholinesterase inhibitory assay and molecular docking were performed to get insight of the inhibitory activity and molecular interactions of the compounds. The compounds showed good to moderate cholinesterase inhibitory activity with IC50 values in the range of 8.06 to 73.23 microM. Compound 7 was found to be the most potent inhibitor of both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Compounds 1, 2, 5 and 6 were found to be selective towards BChE, while compounds 3, 4 and 7 were dual inhibitors, having almost equal inhibitory activity on both AChE and BChE. Molecular docking revealed that compounds 6 and 7 interacted differently on AChE and BChE, by means of hydrophobic interactions and hydrogen bonding. In AChE, the indole moiety of both compounds interacted with the residues lining the peripheral anionic site, whereas in BChE, their methoxy groups are primarily responsible for the strong inhibitory activity via interactions with residues at the active site of the enzyme. CONCLUSION: Two new and five known indole alkaloids were isolated from R. reflexa. Among the compounds, 7 and 6 showed the most potent and promising cholinesterase inhibitory activity, worthy for further investigations.
